CSIQ Financial Statements & Analysis
Complete financial statements for CSIQ including income statement, balance sheet, and cash flow statement. Analyze CSIQ's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-6.6% ↓
Net Income
-388.8% ↓
Gross Margin
10.0% ↑
Operating Margin
253.7% ↑
Balance Sheet
Current Ratio
-4.8% ↓
Debt to Equity
30.3% ↓
Asset Turnover
-16.9% ↓
Cash Flow
Operating Cash Flow
71.5% ↑
Net Cash Flow
50.1% ↑
Free Cash Flow
40.3% ↑
Cash Flow to Debt
78.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 5.99B | 5.60B | 6.6% | |
| Gross Profit | 999.32M | 1.03B | 2.7% | |
| Operating Income | -30.08M | 43.16M | 243.5% | |
| Net Income | 36.05M | -104.13M | 388.8% | |
| EPS | 0.54 | -1.55 | 387.0% | |
| EBITDA | 556.61M | 592.48M | 6.4% | |
| Gross Margin | 16.67% | 18.34% | 10.0% | |
| Operating Margin | -0.50% | 0.77% | 253.7% | |
| Net Income Margin | 0.60% | -1.86% | 409.4% | |
| R&D Expenses | 120.79M | 90.69M | 24.9% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.60B | 5.99B | 7.61B | — | — |
| Gross Profit | 1.03B | 999.32M | 1.28B | — | — |
| Operating Income | 43.16M | -30.08M | 453.32M | — | — |
| Net Income | -104.13M | 36.05M | 274.19M | — | — |
| EPS | -1.55 | 0.54 | 4.27 | — | — |
| EBITDA | 592.48M | 556.61M | 829.66M | — | — |
| Gross Margin | 18.34% | 16.67% | 16.81% | — | — |
| Operating Margin | 0.77% | -0.50% | 5.95% | — | — |
| Net Income Margin | -1.86% | 0.60% | 3.60% | — | — |
| R&D Expenses | 90.69M | 120.79M | 100.84M | — | — |
Financial Metrics
Want to dive deeper into CSIQ's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics